ES557234A0 - Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas. - Google Patents

Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.

Info

Publication number
ES557234A0
ES557234A0 ES86557234A ES557234A ES557234A0 ES 557234 A0 ES557234 A0 ES 557234A0 ES 86557234 A ES86557234 A ES 86557234A ES 557234 A ES557234 A ES 557234A ES 557234 A0 ES557234 A0 ES 557234A0
Authority
ES
Spain
Prior art keywords
oxadiazolil
dihidropiridinas
prepare
procedure
dihydropyridines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES86557234A
Other languages
English (en)
Other versions
ES8900164A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sumitomo Pharma Co Ltd
Original Assignee
Sumitomo Pharmaceuticals Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Pharmaceuticals Co Ltd filed Critical Sumitomo Pharmaceuticals Co Ltd
Publication of ES557234A0 publication Critical patent/ES557234A0/es
Publication of ES8900164A1 publication Critical patent/ES8900164A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/08—1,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ES557234A 1984-10-11 1986-12-01 Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas. Expired ES8900164A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59213786A JPS6191185A (ja) 1984-10-11 1984-10-11 新規なオキサジアゾリル−１，４−ジヒドロピリジン誘導体

Publications (2)

Publication Number Publication Date
ES557234A0 true ES557234A0 (es) 1989-03-01
ES8900164A1 ES8900164A1 (es) 1989-03-01

Family

ID=16645021

Family Applications (2)

Application Number Title Priority Date Filing Date
ES85547724A Expired ES8704162A1 (es) 1984-10-11 1985-10-09 Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos
ES557234A Expired ES8900164A1 (es) 1984-10-11 1986-12-01 Un procedimiento para preparar oxadiazolil 1-4-dihidropiridinas.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES85547724A Expired ES8704162A1 (es) 1984-10-11 1985-10-09 Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos

Country Status (8)

Country Link
US (1) US4705786A (es)
EP (1) EP0177965B1 (es)
JP (1) JPS6191185A (es)
KR (1) KR920008819B1 (es)
AT (1) ATE51229T1 (es)
CA (1) CA1326851C (es)
DE (1) DE3576689D1 (es)
ES (2) ES8704162A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung
NZ219646A (en) * 1986-03-27 1990-10-26 Merck Sharp & Dohme Oxadiazole derivatives of azacyclics for treating cns disorders
US4868181A (en) * 1986-08-04 1989-09-19 E. I. Du Pont De Nemours And Company 1,4-dihydropyridine derivatives with calcium agonist and alpha1 -antagonist activity
GB8830226D0 (en) * 1988-12-23 1989-02-22 Beecham Group Plc Novel compounds
US5276150A (en) * 1989-05-31 1994-01-04 Fujirebio Inc. 1,4-dihydropyridine derivatives
US5670526A (en) * 1995-12-21 1997-09-23 Otsuka Pharmaceutical Co., Ltd. 1,3,4-oxadiazoles
ZA9810320B (en) 1997-11-14 2000-05-11 Gea Farmaceutisk Fabrik As Process for the preparation of 1,4-dihydropyridines and novel compounds of use for such purpose.
DE102006044696A1 (de) * 2006-09-22 2008-03-27 Bayer Healthcare Ag 3-Cyano-5-thiazaheteroaryl-dihydropyridine und ihre Verwendung

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS58150576A (ja) 1982-03-03 1983-09-07 Sumitomo Chem Co Ltd 新規な１，２，４−オキサジアゾ−ル誘導体
US4414213A (en) * 1982-03-22 1983-11-08 Mead Johnson & Company Dihydropyridyl cyclic imidate esters and their pharmaceutical use
DE3247118A1 (de) * 1982-12-20 1984-06-20 Cassella Ag, 6000 Frankfurt Neue substituierte 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3431152A1 (de) * 1984-08-24 1986-03-06 Cassella Ag, 6000 Frankfurt Verfahren zur herstellung optisch aktiver, substituierter 1,4-dihydropyridine und ihre verwendung als arzneimittel
DE3443179A1 (de) * 1984-11-27 1986-05-28 Cassella Ag, 6000 Frankfurt 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung

Also Published As

Publication number Publication date
ES547724A0 (es) 1987-03-16
EP0177965A2 (en) 1986-04-16
ES8704162A1 (es) 1987-03-16
ATE51229T1 (de) 1990-04-15
KR920008819B1 (ko) 1992-10-09
US4705786A (en) 1987-11-10
KR860003244A (ko) 1986-05-21
EP0177965B1 (en) 1990-03-21
CA1326851C (en) 1994-02-08
ES8900164A1 (es) 1989-03-01
JPH0255433B2 (es) 1990-11-27
EP0177965A3 (en) 1987-08-19
JPS6191185A (ja) 1986-05-09
DE3576689D1 (de) 1990-04-26

Similar Documents

Publication Publication Date Title
BR8703970A (pt) Processo e aparelho para mistura hidrodinamica
DK562585D0 (da) Behandling
DE3685633D1 (de) Behandlung von knochenstoerungen.
FI873905A7 (fi) Terapeuttinen koostumus ja menetelmä.
FI880416L (fi) Puun käsittelyseos ja -menetelmä
ES520218A0 (es) Un procedimiento para la preparacion de nuevos 2,3-diaril-5-halotiofenos.
DE68923623D1 (de) Durchführung von teileprogrammen.
ES547724A0 (es) Un procedimiento para preparar oxadiazolil-1,4-dihidropiri- dinas y sus compuestos analogos
PT83778B (pt) Processo para o tratamento de extractos vegetais
ES546090A0 (es) Proceso para preparar tejido implantable para retardar la mineralizacion.
DK325285D0 (da) Behandlingsmetode
DE3381236D1 (de) Produktion von angiogenen faktoren.
IT8620922A0 (it) Analoghi di amminoprostaglandine 5,6-epossi-7-ossabicicloeptano sostituite, utili nel trattamentodi trombosi.
IT8620970A1 (it) Eteri 5,6-epossi-7-ossabicicloeptano sostituiti utili nel trattamento di trombosi
NO854685L (no) Benzamider og salter derav.
IT1062619B (it) Procedimento ed impianto per la depurazione di-stillativa di 2.5 diosso i ossa 2 fosfolani
ES557305A0 (es) Procedimiento para preparar n6 -benzopirano- y benzotiopirano-adenosinas.
DE3579284D1 (de) Herstellung von l-karnitin.
ES547789A0 (es) Procedimiento para preparar tieno- y furo-(2,3-c)-pirroles
IT8520463A0 (it) Trattamento dell'osteoporosi.
DE3675155D1 (de) Sulfoalkylierungsverfahren.
DE3674997D1 (de) Holzbehandlungszusammensetzung.
KR850009221U (ko) 마늘박피기
IT8520448A0 (it) Trattamento dell'osteoporosi.
KR890006070U (ko) 마늘 박피기

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19971001